About IntellxxDNA
IntellxxDNA is a company based in Austin (United States) founded in 2018 by Carol Bilich and Sharon Hausman Cohen. It operates as a B2B and B2C. IntellxxDNA offers products and services including IntellxxDNA Clinical Decision Support Platform and DNA Saliva Collection Kits. IntellxxDNA operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
- Headquarter Austin, United States
- Founders Carol Bilich, Sharon Hausman Cohen
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IntellxxDNA
IntellxxDNA offers a comprehensive portfolio of products and services, including IntellxxDNA Clinical Decision Support Platform and DNA Saliva Collection Kits.
Provides reports on genetic variations for personalized health plans.
Facilitates easy DNA sample collection for genomic analysis.
People of IntellxxDNA
Unlock access to complete
Unlock access to complete
Funding Insights of IntellxxDNA
Detailed funding history for IntellxxDNA
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IntellxxDNA
Investment portfolio details for IntellxxDNA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IntellxxDNA
Detailed financials for IntellxxDNA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Intellxxdna Comparisons
Peer comparison for IntellxxDNA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IntellxxDNA
IntellxxDNA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
|
| Locked | Locked | Locked |
Diagnostic services are provided through laboratories and radiology units.
|
Detailed competitors of IntellxxDNA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Intellxxdna
Complete news archive for IntellxxDNA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IntellxxDNA
IntellxxDNA was founded in 2018.
IntellxxDNA is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Carol Bilich is the current CEO of IntellxxDNA. They have also founded this company.
IntellxxDNA is a platform that analyzes DNA to deliver personalized genomic reports and clinical decision support for healthcare professionals and individuals. It uses saliva-based testing to identify genetic variations influencing health, enabling customized treatment plans for conditions like autism and cognitive decline. Based in Austin, Texas, it serves clinicians and patients by integrating functional medicine principles to improve outcomes and prevent diseases through evidence-based recommendations.
IntellxxDNA's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.
IntellxxDNA offers IntellxxDNA Clinical Decision Support Platform and DNA Saliva Collection Kits.